Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

This publication has 48 references indexed in Scilit:

• A Systematic Review of Mortality in Schizophrenia
  Archives of General Psychiatry, 2007
• Long-Term Changes in Weight and Plasma Lipids during Maintenance Treatment with Ziprasidone
  Neuropsychopharmacology, 2007
• Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
  BMC Psychiatry, 2007
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
  Diabetic Medicine, 2006
• An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes
  American Journal of Epidemiology, 2005
• Second-Generation (Atypical) Antipsychotics and Metabolic Effects
  CNS Drugs, 2005
• The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study
  Atherosclerosis, 2004
• The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry
  International Journal of Obesity, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS)
  Diabetes/Metabolism Research and Reviews, 2001